High MSLN expression in human cancer cell lines, including ovarian cancer, has been associated with tumor cell adhesion, increased tumor burden, invasion through mesothelial cells, dissemination within the peritoneal cavity and chemoresistance [1,9,10,11,12]. This evidence concerns the gene MSLN and ovarian carcinoma.